Journals / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 5

A comparative analysis of the COVID-19 pandemic response: The case of Turkey

Pages
443–451
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

China and South Korea were best at managing COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: COVID-19 has spread worldwide and leads to an increased risk of mortality.
📊
Key Findings & Data:We aimed to analyze what actions have been effective in fighting COVID-19 in Turkey with a comparison to pandemic-affected countries.Methods: This was a retrospective observational cross-sectional study.
💡
Conclusion & Impact:China and South Korea were best at managing COVID-19.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: COVID-19 has spread worldwide and leads to an increased risk of mortality. We aimed to analyze what actions have been effective in fighting COVID-19 in Turkey with a comparison to pandemic-affected countries.Methods: This was a retrospective observational cross-sectional study. The Republic of Turkey Ministry of Health official web page includes data reported daily from 11 March to 26 April. Global COVID-19 data were recorded daily from https://www.worldometers.info/coronavirus/country/. Data were analyzed for 31 days according to Intensive Care Unit (ICU) admission, intubation and mortality rates. Segmented regression analysis was used. The results from COVID-19-affected countries were compared with the results from Turkey for the first 65 days.Results: In total, 889.742 tests were performed (positive=110.130 [12.37%]). The mortality rate was 2.55% (n=2805) on 27 April 2020. The annual percent change (APC) values of the cases showed 5 segments ([23.1], [14.7] [11.4], [3.7], [0.7]; each p=0.001). ICU admission showed 4 segments (APC: [3.1, p=0.001], [-2.2, p=0.10], [-7.6, p=0.001], [-4.5, p=0.001]). The decline of APC for intubation rates showed 5 segments (APC: [1.1, p=0.10], [-1.1,p=0.001], [-2.0, p=0.001], [-0.4, p=0.40], [-2.7, p=0.001]). The mortality rates showed 4 segments (APC: [-6.3, p=0.001], [8.4, p=0.001], [0.2, p=0.30], [1.4, p=0.001]). Deaths were reported per 1 million individuals for the first 65 days: Spain 11.6%, Italy 11.4%, UK 11.3%, France 11.1%, USA 10.3%, Germany 8.4%, Iran 8.2%, Turkey 7.5%, South Korea 4.1% and China 2.4%.Conclusion: Public health policies and protocols to combat COVID-19 helped control the spread and decrease positive cases and mortality rates in Turkey. Turkey managed COVID-19 better than Spain, Italy, UK, France, USA and Turkey managed COVID-19 similarly to Germany and Iran. China and South Korea were best at managing COVID-19.

🔖

Cite This Article

ŞİMŞEK, E. E., KARAKURT, Z., TEKESİN, K., KUL, S., GÜNER, A. E., BİRİNCİ, S. (2022). A comparative analysis of the COVID-19 pandemic response: The case of Turkey. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 5, 443–451. https://ajindex.com/articles/551340

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol 2020;18:123
  2. Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med 2020;27:taaa008
  3. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020;83:217–20
  4. WHO. WHO Director-General’s opening remarks at the Mission briefing on COVID-19. Available at: https://www.who.int/dg/speeches/ detail/who-director-general-s-opening-remarks-at-themissionbriefing- on-covid-19. Accessed Mar 12, 2020
  5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506
  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708– 20
  7. Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27 [Epub ahead of print], doi: 10.1093/cid/ciaa478
  8. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. Lancet Child Adolesc Health 2020;4:397–404
  9. Wunsch H. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology. Am J Respir Crit Care Med 2020;202:1–4
  10. Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. Am J Respir Crit Care Med 2020;201:1430–4
  11. Ministry of Health (2020). COVID-19 New Corona Virus. Available at: https://covid19.saglik.gov.tr/. Accessed Sep 25, 2020
  12. Worldometer COVID-19 Coronavirus Pandemic, Countries. Available at: https://www.worldometers.info/coronavirus/. Accessed Sep 25, 2020
  13. World Health Organization. Coronavirus disease (COVID-19) pandemic. Available at: https://www.who.int/emergencies/diseases/novel- coronavirus-2019. Accessed Sep 25, 2020
  14. Demirbilek Y, Pehlivantürk G, Özgüler ZÖ, Alp Meşe E. COVID-19 outbreak control, example of ministry of health of Turkey. Turk J Med Sci 2020;50:489–94
  15. Koçak Tufan Z, Kayaaslan B. Crushing the curve, the role of national and international institutions and policy ma